Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . June 24th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Liver Failure - Therapies extend use of often-rejected livers for patient transplantation
Metabolism - Lack of normal cholesterol synthesis may reveal liver graft dysfunction
Antiviral Cleansing - Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients
Hepatitis B Therapy - Preliminary trial suggests emtricitabine effective against hepatitis B
Liver Toxins - Cigarette chemicals leave hepatitis B patients more prone to cancer
Pulmonary Function - Subclinical lung disease a possibility in those with hepatitis C virus
Finance - Company reports 17.7% sales increase in the first quarter
Finance - Strong first quarter positions Baxter well to meet full year 2002 commitments
Healthcare Costs - Study shows digestive, liver woes cost nation $85.5 billion annually
Hepatitis C - BioMedicines completes phase II enrollment with Omega interferon
Hepatitis C - Foundation International presses Capitol Hill on health education
Hepatitis C - SciClone begins U.S. phase III clinical trials for Zadaxin
Hepatitis C - Study highlights need for vaccine
Hepatitis C Therapy - Consensus interferon may work when other regimens are ineffective
Infectious Disease - Protection against malaria, herpes, and cancer reported with new peptide
Needlestick Injuries - Horizon gets FDA clearance on new lifeguard safety needle
Primary Liver Cancer - Annexin A10 gene could be target for gene therapy in hepatocellular carcinoma
Transfusion Medicine - Parents' blood donations less safe than previously thought
Transplant Complications - Study links liver transplants for hepatitis C with onset of diabetes mellitus
Transplantation Complications - Pneumonia a risk when splenectomy accompanies liver transplantation
Viral Screening - Automated chemiluminescent immunoassay an alternative to NAT
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
